|
Jan 4
|
This Johnson & Johnson Insider Reduced Their Stake By 37%
|
|
Jan 3
|
The Descent of an Army Vet Turned Corporate Consultant Named in the New Year’s Attack
|
|
Jan 2
|
Neumora Therapeutics Stock Crashes 81% After Depression Drug Flops
|
|
Jan 2
|
5 Low-Leverage Stocks Worth Adding to Your Portfolio in 2025
|
|
Jan 2
|
Johnson & Johnson Declares Dividend, Short Interest Declines
|
|
Jan 2
|
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
|
|
Jan 1
|
Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
|
|
Jan 1
|
The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024
|
|
Dec 31
|
Is Johnson & Johnson (JNJ) Among the Best Low Volatility Stocks to Buy Right Now?
|
|
Dec 31
|
Investors in Johnson & Johnson (NYSE:JNJ) have unfortunately lost 8.8% over the last three years
|
|
Dec 31
|
Here’s Why WisdomTree U.S. LargeCap Dividend Fund (DLN) Is One of the Best Performing Dividend ETFs in 2024
|
|
Dec 30
|
Is Johnson & Johnson (JNJ) the Best Pharma Dividend Stock to Buy In 2024?
|
|
Dec 30
|
5 Unbeatable Stocks I'm Eager to Buy in 2025
|
|
Oct 4
|
Sector Update: Health Care Stocks Steady Late Afternoon
|
|
Oct 4
|
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
|
|
Oct 4
|
Sanofi Healthcare Bidders Revising Offers Over Talc Concerns
|
|
Oct 4
|
J&J discontinues dengue drug study after changes in R&D portfolio
|
|
Oct 4
|
Wells Fargo says there is a risk that Johnson & Johnson will guide lower
|
|
Oct 4
|
Opdivo gets ‘perioperative’ approval; pharmas cut jobs in New Jersey, Ireland
|
|
Oct 4
|
2 Smart Income Stocks to Buy Right Now
|